Header Logo

Connection

Idoroenyi Amanam to Oncogene Proteins, Fusion

Back to Details
This is a "connection" page, showing publications Idoroenyi Amanam has written about Oncogene Proteins, Fusion.
Idoroenyi Amanam
Connection Strength
0.139
Oncogene Proteins, Fusion
  1. The brigatinib experience: a new generation of therapy for ALK-positive non-small-cell lung cancer. Future Oncol. 2018 Aug; 14(19):1897-1908.
    View in: PubMed
    Score: 0.139
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.